[Clinical experiences with the new protease inhibitor Contrybal. Current status of combined therapy of pancreatitis].
D000038:Abscess / Q000188:drug therapy; D003560:Cysts / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D010181:Pancreatic Cyst / Q000188:drug therapy; D010182:Pancreatic Diseases / Q000188:drug therapy; D010195:Pancreatitis / Q000188:drug therapy* / Q000601:surgery; D010309:Parotitis / Q000188:drug therapy*; D011183:Postoperative Complications / Q000188:drug therapy; D014361:Trypsin Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*
D014361:Trypsin Inhibitors
Klinische Erfahrungen mit dem neuen Proteaseninhibitor Contrykal. Derzeitiger Stand der komplexen Pankreatitisbehandlung.